Monitra Health: Redefining Cardiac Care from India to the World

Monitra Health wasn’t born in a boardroom; it was born in an ICU. Co-founder Ravi Bhogu’s grandfather, a healthy 92-year-old, fainted without warning. The cause: a heart rhythm disorder. The experience triggered not only a personal transformation but a professional mission.

After years leading med-tech programs at Johnson & Johnson and other global firms, Bhogu saw the problem from both sides—technical and human. Heart rhythm disorders (HRDs) are a silent, widespread threat, yet they often go undiagnosed until it's too late.

Building for Bharat, Scaling for the World

Founded in Hyderabad by Ravi, Aparna, and Sashank Bhogu, Monitra Health is rooted in a clear mission: to create clinically robust, scalable, and accessible solutions for cardiac monitoring.

Their innovation is grounded in three principles—global quality, cost-effective delivery, and scalability across India’s Tier 1 to Tier 4 cities. “If we can solve this problem at scale in India, we can solve it anywhere,” Bhogu affirms.

The Breakthrough: upBeat

Monitra’s flagship product, upBeat, is a globally patented, full-stack cardiac monitoring platform that brings real-time, high-fidelity ECG tracking into everyday settings.

It closes the diagnostic gap by enabling continuous, remote cardiac rhythm monitoring with features that rival and often surpass global standards:

• XtremeSpan and NanoVue technologies: Deliver unmatched signal quality and diagnostic precision
• Highest ECG input voltage range and resolution: Capture subtle arrhythmic indicators in noisy environments
• Auto-orientation tech: Prevents electrode misplacement for self-administered use
• Precision Workflow Engine: Eliminates false positives and negatives, streamlining diagnosis
• Rapid visualisation and symptom-event correlation: Enables swift, accurate clinical decisions

upBeat is more than a standalone device; it functions as a platform for rhythm diagnostics, supporting data analysis and facilitating clinical decision-making across the continuum of cardiac care.

An Underserved Global Problem

Heart rhythm disorders are often masked by common symptoms, fatigue, dizziness, and palpitations, leading to misdiagnosis or missed detection. In emerging markets, the infrastructure to monitor patients continuously is limited. Providers struggle, patients suffer, and healthcare systems bear unnecessary costs.

Monitra Health is solving for this with a solution designed specifically for fragmented ecosystems.

Clinically Embedded, Globally Validated

Today, over 30,000 patients have been monitored using upBeat across 1.44 million hours of analysis. More than 1,000 doctors and 50 hospitals—including Apollo, AIG, and Manipal- trust the platform for routine diagnostics. Clinical findings have been showcased at international forums like the European Heart Rhythm Association Congress, and the product is currently involved in global trials like Aspire AF.

Business Model: Scalable, Sustainable, Clinically Trusted

Monitra operates on a dual delivery model that includes a Prescribing Model, where specialists prescribe continuous ECG monitoring, and a Provider Model, where hospitals and clinics integrate upBeat into their outpatient workflows.

Its revenue streams are structured around a pay-per-use approach, recurring reporting fees, and strategic partnerships with insurers, med-tech firms, and digital health platforms. This model is designed for cash efficiency, steady recurring income, and adaptability across global healthcare markets.

Institutional Support and Global Expansion

Monitra’s journey has been powered by institutions like T-Hub, IKP, BIRAC, USISTEF, and NASSCOM.

Regulatory certifications in India are secured, and FDA, CE, and TGA approvals are underway. International pilots are active in Nepal and the Caribbean, with expansion talks ongoing in the UK, Australia, and Southeast Asia.

Competitive Landscape and Why Monitra Stands Out

Global players such as iRhythm and BioTelemetry serve developed markets with trusted, comprehensive offerings. Indian firms like Tricog and consumer-focused solutions such as AliveCor are helping expand access and awareness around cardiac monitoring.

Monitra Health complements these efforts by offering solutions tailored for emerging healthcare environments, combining scalability, clinical integration, and affordability.

With a unique combination of full-stack platform ownership, globally patented innovations, and clinically embedded use-cases, Monitra addresses existing gaps in outpatient rhythm diagnostics. Its offering is designed to meet the evolving needs of diverse healthcare systems, especially in resource-constrained settings.

Lessons in Building from India

Monitra’s journey has been shaped by the realities of India's healthcare ecosystem. Clinical trust is paramount. Technology alone isn’t enough; real-world outcomes matter. Designing for India means addressing the vast diversity in workflows and infrastructure. The founding team’s shared conviction, empathy, and grit have been crucial in navigating long regulatory cycles while maintaining urgency for patients.

Vision for the Future

Over the next 18 months, Monitra aims to expand across India's underserved regions, reach breakeven, and secure global regulatory approvals. Its five-year roadmap includes scaling across Asia, Africa and Latin America—markets where decentralised, digital diagnostics can leapfrog traditional systems—as well as strategic entry into developed markets such as the US, EU, ANZ and Japan, where demand for cost-effective, scalable cardiac monitoring is growing.